HCID 178418800, Verbindung → 1-(2,4-Dichlorophenyl)-2-(4-methylimidazol-2-yl)ethan-1-one
Reaktionsgleichung
[Cl:1][C:2]1[CH:7]=[C:6]([Cl:8])[CH:5]=[CH:4][C:3]=1[C:9](=[O:16])[CH2:10][C:11]1C=CN[N:12]=1.[CH3:17][C:18]1[N:19]=CN[CH:22]=1>>[Cl:1][C:2]1[CH:7]=[C:6]([Cl:8])[CH:5]=[CH:4][C:3]=1[C:9](=[O:16])[CH2:10][C:11]1[NH:12][CH:17]=[C:18]([CH3:22])[N:19]=1Komponenten
3
Versuchsvorschrift
Made using the same procedure as for 1-(2,4-dichlorophenyl)-2-pyrazolylethan-1-one except that 4-methylimidazole (3.7 g, 44.8 mmol) was used in place of pyrazole. The crude residue was purified on silica gel (5% MeOH/CH2Cl2) to yield a light yellow solid.
Aufarbeitung
- customThe crude residue was purified on silica gel (5% MeOH/CH2Cl2)
- customto yield a light yellow solid
Quellen und Nachweise
- ORD-Eintrag
- ord-06f7342312d747f58e4a892ae58493e0
- Quelldatensatz
- uspto-grants-2006_05
- Patentnummer
- US07037918B2
Notizen zur Reaktion
Wird geladen…